Breaking Update: Here’s a clear explanation of the latest developments related to Breaking News:Childhood cancer in India rising among top causes of death with late diagnosis challenges– What Just Happened and why it matters right now.
Cancer has quietly become one of the leading causes of death among children in India, ranking among the top ten, according to recent findings by an analysis in The Lancet – an alarming signal of a growing but still under-recognised public health challenge.
The data in the Global Burden of Diseases, 2023, point to a stark reality: even as infectious diseases decline, non-communicable conditions like cancer are emerging as significant threats to child survival.
In India, this epidemiological shift is particularly concerning because childhood cancers, though relatively rare, are often highly treatable when detected early – yet too many cases are diagnosed late.
According to the Indian Council of Medical Research’s National Centre for Disease Informatics and Research (ICMR-NCDIR), childhood cancers accounted for roughly 3–5 percent of all cancers in India in 2022.
The country sees an estimated 50,000 to 60,000 new cases every year among children aged 0–14 years, making it one of the highest burdens globally.
Globally in 2023, there were 377,000 new cases of childhood cancer and 144,000 deaths worldwide in 2023, according to The Lancet research paper.
THE HIDDEN BURDEN
Leukaemias or blood cancers are the most common childhood cancers in India, followed by lymphomas and central nervous system tumours, the statistics show.
Together, these three categories account for the majority of paediatric cancer cases. The incidence rates vary across regions, with urban registries such as Delhi reporting higher rates, partly due to better detection and reporting systems.
However, experts believe the actual burden is likely higher. Incomplete cancer registration and limited access to diagnostic facilities – especially in rural and underserved areas – mean that many cases remain unreported or are diagnosed too late.
“A major driver of poor outcomes in India is delayed diagnosis. Early symptoms of childhood cancers such as fever, fatigue, unexplained weight loss, or swelling-often mimic common infections,” pointed out an oncologist with Delhi State Cancer Institute.
This leads to delays at multiple levels, from caregivers not recognising warning signs to primary care providers missing early clues, added the oncologist.
The ICMR 2022 factsheet highlights that a significant proportion of children reach specialised cancer centres only at advanced stages of disease. By then, treatment becomes more complex, more expensive, and less likely to succeed.
Access to care remains uneven. Paediatric oncology services are concentrated in tertiary hospitals in large cities, forcing families from smaller towns and rural areas to travel long distances.
This geographic imbalance contributes to treatment delays and interruptions, particularly for economically vulnerable families.
Financial hardship is another critical barrier. Even when treatment is subsidised, indirect costs – travel, accommodation, lost income – can be overwhelming. As a result, treatment abandonment remains a serious issue in India, directly affecting survival rates.
UNEVEN SURVIVAL
Globally, survival rates for childhood cancers exceed 80 percent in high-income countries. In India, outcomes are improving but remain uneven. The ICMR factsheet in 2022 noted that survival can vary widely depending on the type of cancer, stage at diagnosis, and where the child is treated.
Centres of excellence in India have reported survival rates approaching those seen in developed countries for certain cancers, particularly acute lymphoblastic leukaemia. However, these outcomes are not representative nationwide.
The gap highlights systemic inequities. Children treated in well-equipped urban centres with multidisciplinary teams tend to fare much better than those in resource-limited settings.
At the same time, improving survival has brought new challenges. Long-term follow-up care for survivors – addressing late effects of treatment such as secondary cancers, organ damage, or developmental issues – is still underdeveloped in India’s health system.
The ICMR factsheet also underscored the need for a dedicated approach to paediatric cancers, including specialised infrastructure, trained healthcare professionals, and stronger referral systems. It also calls for expanding population-based cancer registries to generate more reliable and comprehensive data.
– Ends